Camurus
531.00 SEK
+0.38 %
Less than 1K followers
CAMX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Camurus
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 84.50 | 186.40 | 150.80 | 252.60 | 538.00 | 565.50 | 616.00 |
| Shares | 48.0 | 52.0 | 54.8 | 55.1 | 55.6 | 58.9 | 59.9 |
| Market cap | 4,054.0 | 9,692.8 | 8,268.2 | 13,910.0 | 29,925.5 | 33,296.1 | 36,886.2 |
| Enterprise value | 3,722.6 | 9,272.1 | 7,882.3 | 13,370.7 | 28,760.2 | 30,460.4 | - |
| EV/S | 35.2 | 27.6 | 13.1 | 14.0 | 16.8 | 16.3 | - |
| EV/EBITDA | neg. | neg. | neg. | 185.8 | 54.7 | 64.9 | - |
| EV/EBIT | neg. | neg. | neg. | 185.8 | 54.7 | 64.9 | - |
| P/E | neg. | neg. | neg. | 250.1 | 69.2 | 76.5 | 49.6 |
| P/B | 6.42 | 11.44 | 9.74 | 13.98 | 20.04 | 10.12 | 8.71 |
| P/S | 38.4 | 28.8 | 13.8 | 14.5 | 17.4 | 17.8 | 16.3 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 81.8 % | 81.2 % | 78.5 % | 76.2 % | 78.3 % | 87.6 % | 89.4 % |
| Gearing ratio | 4.3 % | 4.8 % | 3.0 % | 2.6 % | 1.6 % | 0.5 % | 2.5 % |